CEREP Inactive Instrument
Company CEREP Euronext Paris
Equities
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 2023 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2022 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
Business Summary
Exports account for 97.9% of net sales.
Sales per Business
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Preclinical Drug Research Services
100.0
%
| 42 | 100.0 % | 48 | 100.0 % | +14.45% |
Sales per region
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
International
97.7
%
| 38 | 90.9 % | 47 | 97.7 % | +23.05% |
France
2.3
%
| 4 | 9.1 % | 1 | 2.3 % | -71.19% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18-04-18 | |
Damien Séroux
CHM | Chairman | - | 14-10-12 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Damien Séroux
CHM | Chairman | - | 14-10-12 |
| Director/Board Member | 68 | 15-06-09 | |
| Chief Executive Officer | - | 18-04-18 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 5,044 | 213 ( 4.223 %) | 0 | 4.223 % |
Company contact information
Eurofins-Cerep SA
Le bois l'Evêque
86600, Celle l'Evescault
+33 5 49 89 30 00
http://www.eurofins.fr/cerep/
Sector
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- ALECR Stock
- Stock
- Company CEREP
